A detailed history of Quantamental Technologies LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Quantamental Technologies LLC holds 9,594 shares of MRK stock, worth $953,355. This represents 0.94% of its overall portfolio holdings.

Number of Shares
9,594
Holding current value
$953,355
% of portfolio
0.94%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$102.95 - $114.33 $987,702 - $1.1 Million
9,594 New
9,594 $987,000
Q1 2023

May 15, 2023

BUY
$102.94 - $114.86 $473,318 - $528,126
4,598 New
4,598 $489,000
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $764,573 - $858,913
9,045 New
9,045 $779,000
Q2 2022

Aug 15, 2022

SELL
$83.49 - $94.64 $346,900 - $393,229
-4,155 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$73.51 - $82.4 $462,745 - $518,708
-6,295 Reduced 60.24%
4,155 $341,000
Q4 2021

Feb 14, 2022

BUY
$72.28 - $90.54 $755,326 - $946,143
10,450 New
10,450 $801,000
Q4 2020

Feb 16, 2021

SELL
$71.77 - $79.65 $954,038 - $1.06 Million
-13,293 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$73.18 - $82.95 $594,514 - $673,885
-8,124 Reduced 37.93%
13,293 $1.1 Million
Q2 2020

Aug 14, 2020

BUY
$70.42 - $80.13 $1.51 Million - $1.72 Million
21,417 New
21,417 $1.66 Million
Q1 2020

May 15, 2020

SELL
$63.36 - $87.82 $425,335 - $589,535
-6,713 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$77.58 - $87.54 $411,018 - $463,786
5,298 Added 374.42%
6,713 $611,000
Q3 2019

Nov 08, 2019

SELL
$76.08 - $82.93 $315,047 - $343,413
-4,141 Reduced 74.53%
1,415 $119,000
Q2 2019

Aug 12, 2019

BUY
$69.84 - $81.59 $308,203 - $360,056
4,413 Added 386.09%
5,556 $466,000
Q1 2019

Apr 29, 2019

SELL
$69.58 - $79.36 $19,412 - $22,141
-279 Reduced 19.62%
1,143 $95,000
Q4 2018

Jan 28, 2019

BUY
$65.24 - $75.71 $92,771 - $107,659
1,422 New
1,422 $109,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Quantamental Technologies LLC Portfolio

Follow Quantamental Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantamental Technologies LLC with notifications on news.